Companies: 49,246 Total Market Cap: 132578865767700.31

Beximco Pharmaceuticals Limited

DSE-BXPHARMA
Pharmaceutical Preparations
Rank #16667
Market Cap 321.43 M
Volume 328,283
Price 0.72
Change (%) 1.03%
Country or region Bangladesh Bangladesh

Beximco Pharmaceuticals Limited's latest marketcap:

321.43 M

As of 05/20/2025, Beximco Pharmaceuticals Limited's market capitalization has reached $321.43 M. According to our data, Beximco Pharmaceuticals Limited is the 16667th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 321.43 M
Revenue (ttm) 376.43 M
Net Income (ttm) 51.61 M
Shares Out 446.11 M
EPS (ttm) 0.12
Forward PE 6.98
Ex-Dividend Date 11/26/2024
Earnings Date 04/30/2025
Market Cap Chart
Data Updated: 05/20/2025

Beximco Pharmaceuticals Limited's yearly market capitalization.

Beximco Pharmaceuticals Limited has seen its market value drop from 84.98 B BDT to 39.57 B BDT since 2020, representing a total decrease of 53.44% and an annual compound decline rate (CAGR) of 15.99%.
Date Market Cap(BDT) Change (%)
05/20/2025 39.57 B 5.02%
12/30/2024 36.40 B -44.19%
12/28/2023 65.22 B 0%
12/29/2022 65.22 B -24.13%
12/30/2021 85.97 B 1.15%
12/30/2020 84.98 B

Company Profile

About Beximco Pharmaceuticals Limited

Beximco Pharmaceuticals Limited is a leading manufacturer and marketer of generic pharmaceutical formulations and active pharmaceutical ingredients (APIs) in Bangladesh. Established in 1976 and headquartered in Dhaka, the company serves both domestic and international markets.

Product Portfolio

The company offers a diverse range of pharmaceutical products, including:

  • Allergic disorder treatments
  • Analgesics and antipyretics
  • Anti-infectives and antivirals
  • Cardiovascular and CNS medications
  • Cough, cold, and respiratory products
  • Endocrine and diabetes care
  • Eye care and gastrointestinal solutions
  • Hormones, steroids, and IV fluids
  • Oncology and musculoskeletal treatments
  • Urogenital and skincare products
  • Vitamin and mineral supplements

Dosage Forms

Beximco Pharmaceuticals produces medications in various forms:

  • Solid and liquid formulations
  • Creams, ointments, and suppositories
  • Metered dose and dry powder inhalers
  • Nasal sprays and sterile injectables
  • Lyophilized injectables and large volume IV fluids

Additional Services

The company provides contract manufacturing services to other pharmaceutical firms, leveraging its expertise in generic drug production.

With operations spanning since 1976, Beximco Pharmaceuticals continues to expand its presence through both domestic operations and exports to international markets.

Frequently Asked Questions

As of 05/20/2025, Beximco Pharmaceuticals Limited (including the parent company, if applicable) has an estimated market capitalization of $321.43 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Beximco Pharmaceuticals Limited global market capitalization ranking is approximately 16667 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Bangladesh
Founded 1976
IPO Date n/a
Employees 1,122
CEO Iqbal Ahmed
Sector
Industry Pharmaceutical Preparations
Address 19 Dhanmondi R/A
Dhaka, 1205
Bangladesh
Website https://www.beximcopharma.com